#Pardes trial#

All of the stories will highlight choices made in the aftermath of trauma and upheaval. Over the course of the seminar, Biblical texts will be studied that reflect narratives of men and women, alone and together, facing difficult and at times unthinkable challenges. They can help us reach into the innermost parts of our lives and inspire us to embrace our vulnerability and emerge triumphant. Our Jewish texts, from the Bible to the Talmud, from Hasidut to Halakhic Responsa, contain blueprints to guide us in the challenges of the moment. How can we nurture an inner core that enables us to respond dauntlessly and wisely to the needs of the hour while simultaneously preparing for an uncertain future? Students of all educational backgrounds are warmly welcomed. Join Pardes for an inspiring week of meaningful Torah study! Guided by PardesвЂ™s acclaimed faculty, we will explore Jewish textual approaches to cultivating courage and resilience, challenges we have all faced this past year. Read more about Stephen DonshikвЂ™s Pardes Learning Seminar experience at: Seminar Overview вЂ¦it is a luxury to learn in an atmosphere that empowers participants to seek knowledge and information that will enable them to make their own decisions about their spiritual and religious lives.

The Seminar is open to individuals of all Jewish educational backgrounds, from novice to expert. The combination of studying Jewish texts and ideas, together with exploring Israel, brings the classroom learning to life and allows you to see Israel in a whole new way. Through classes, touring and social events, participants have the opportunity to connect with peers and expand their personal networks. Participants from around the world come together to create a cohort of passionate learners exploring Jewish themes that are challenging and inspiring. Sources are provided in their original language and in English translation. Participants study in havruta pairs, partnering to help one another explore and gain ownership of the text. Our renowned faculty bring together students from diverse learning backgrounds and create an educational environment that is accessible and empowering. They aim not only to teach compelling ideas, but also to give you the tools to enter personally into a conversation with your heritage. Notable companies such as Pfizer as well as Merck with partner Ridgeback Biotherapeutics, are also working to develop such antiviral therapies.The Pardes facultyвЂ™s depth of knowledge is rivaled only by their engaging teaching style and their ability to bring Judaism to life. If people infected with SARS-CoV-2 вЂњare not making as much virus, they are less likely to infect other people,вЂќ he said. вЂњThis goes back to breaking the replication machinery,вЂќ said Lopatin. Oral antivirals offer promise in battling the pandemic in the long term in terms of reducing the severity of COVID-19 infections and potentially reducing transmission.

#Pardes trial#

Last month, the company announced that it had launched a first-in-human trial for its SARS-CoV-2 antiviral.

The company filed its first patent applications in April 2020. вЂњThis issued patent is the first from our growing IP portfolio and reflects our commitment to discovering and developing novel therapies for important unmet medical needs,вЂќ said Uri Lopatin, the companyвЂ™s CEO, in a statement. The patent relates to compounds intended to inhibit the main protease (Mpro) of SARS-CoV-2. Patent and Trademark Office has issued a new patent No. Pardes Biosciences, a biopharma upstart based in Carlsbad, California, has announced that the U.S.